Identification of a Recurrent <i>LMO7–BRAF</i> Fusion in Papillary Thyroid Carcinoma - Concepedia

Concepedia

Publication | Open Access

Identification of a Recurrent <i>LMO7–BRAF</i> Fusion in Papillary Thyroid Carcinoma

DOI Full Paper Access

27

Citations

23

References

2018

Year

Huiling He, Wei Li, Pearlly S. Yan, Ralf Bundschuh, Jackson A. Killian, Jadwiga Labanowska, Pamela Brock, Rulong Shen, Nyla A. Heerema, Albert de la Chapelle

Abstract

A novel fusion gene, LMO7-BRAF, was identified in PTC tumors. The results indicate that the LMO7-BRAF fusion behaves as an oncogenic alteration. This observation expands the spectrum of fusion genes involving kinases in thyroid cancer.

References

	Year	Citations
Cancer statistics, 2017 Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal CA A Cancer Journal for Clinicians Epidemiology Of CancerPopulation Health SciencesCancer RegistrationUnited StatesCancer Risk Factors	2017	14.9K
Primer3—new capabilities and interfaces Andreas Untergasser, Ioana Cutcutache, Triinu Kõressaar, Nucleic Acids Research	2012	9.5K
Integrated Genomic Characterization of Papillary Thyroid Carcinoma Nishant Agrawal, Rehan Akbani, Bülent Arman Aksoy, Cell	2014	3K
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 Hyeyeun Lim, Susan S. Devesa, Julie Ann Sosa, JAMA	2017	2.1K
Current Thyroid Cancer Trends in the United States Louise Davies, H. Gilbert Welch JAMA Otolaryngology–Head & Neck Surgery	2014	1.6K
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) Poulikos I. Poulikakos, Yogindra Persaud, Manickam Janakiraman, Nature PharmacologyRaf Inhibitor ResistanceMolecular BiologyDrug Resistance	2011	1.4K
The landscape of kinase fusions in cancer Nicolas Stransky, Ethan Cerami, Stefanie S. Schalm, Nature Communications	2014	936
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC Paula Soares, Vítor Trovisco, Ana Sofia Rocha, Oncogene Genome InstabilityAlternative EventsCell DivisionBraf MutationsGenetics	2003	677
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma Nallasivam Palanisamy, Bushra Ateeq, Shanker Kalyana‐Sundaram, Nature Medicine Systems BiologyMedicineReceptor Tyrosine KinaseGastric CancerTumor Suppressor	2010	468
The landscape and therapeutic relevance of cancer-associated transcript fusions Kosuke Yoshihara, Qing Wang, Wandaliz Torres‐García, Oncogene Tumor BiologyTherapeutic RelevanceMedicineCancer GenomicsCancer Biology	2014	452

Page 1